tiprankstipranks
The Fly

Unicycive Therapeutics expects cash to fund operations into 2026

Unicycive Therapeutics expects cash to fund operations into 2026

As of September 30, 2024, cash and cash equivalents totaled $32.3 million. The Company believes that it has sufficient resources to fund planned operations into 2026.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

1